Sunflower Therapeutics, PBC — Form D
Sunflower Therapeutics, PBC of Hingham, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-14. The offering totals $1.5M, of which $610K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-10-14
- Form: D
- Accession: 0001950773-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $610K
- Remaining: $890K
- Investors: 8
- Date of first sale: 2022-09-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-461831
Issuer
- Name: Sunflower Therapeutics, PBC
- CIK: 0001950773
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 18 Shipyard Dr., Ste. 2A, Hingham, MA, 02043
- Phone: 781-539-8100
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Kathryn R Golden | Director | Hingham, MA |
| Larry R Weiner | Director | Hingham, MA |
| J. Christopher R Love | Director | Hingham, MA |
| Maik R Jornitz | Director | Hingham, MA |
| Kerry R Love | Director | Hingham, MA |
| Kerry R Love | Executive Officer | Hingham, MA |
Other filings by this issuer (1)
More